Compounding Pharmacy Consultant Christopher (Chris) J. Smalley was honored with the Frederick J. Carlton Award at the 2018 Parenteral Drug Association (“PDA”) Annual Meeting in Orlando, Florida. Presented as a tribute to lifetime PDA contributor Fred Carlton, the award is given annually to past or present PDA board members for their continuous and notable volunteer service to the association.
“I had the pleasure of knowing former PDA Executive Director Fred Carlton, and the honor of being his friend,” Smalley commented. “The PDA we know today exists in large part because of Fred’s significant contributions to its structure and mission. I hope that my work within the association honors his legacy.”
Chris Smalley, an experienced sterile compounding pharmacist, works with pharmacists to design, build and operate compliant compounding facilities. His service to PDA includes 16 years on the PDA Science Advisory Board, two terms on the Board of Directors, and 12 years leading the Facilities & Engineering Interest Group. He’s facilitated workshops on Single Use Systems and Knowledge Management and was a contributing author to several technical reports, including Steam Sterilization, Quality Risk Management, Single Use Systems and Drug Shortages. He previously led the Program Committee for the PDA Annual Meeting and currently serves on task forces for Data Integrity and Isolators.
Smalley recently retired from Merck, where he worked for five years on innovative implementation and validation, including Single Use Systems globally. Previously, he was Director of Quality Operations for Wyeth Pharmaceuticals for 12 years with responsibility for setting validation standards and validation activities globally. His research experience includes responsibility for Quality in the U.S. operations of the Sanofi Research Division, and earlier as a plant manger for the Johnson & Johnson family of companies. Currently, he is a member of the ISPE Disposables CoP.